← All indications
Pelvic Pain
Pain in the pelvic region of genital and non-genital origin.
Subtype terms (3)
More specific conditions that are subtypes of Pelvic Pain in the MeSH hierarchy.
- Dysmenorrhea
82 drugs (43 approved, 39 experimental)
- Pelvic Girdle Pain
1 drug approved
- Piriformis Muscle Syndrome
2 drugs (1 approved, 1 experimental)
Drugs by status
Phase 4 trials (12)
Phase 3 trials (12)
Phase 2 trials (8)
Organizations
Organization Involved with Phase 4 Indications (22)
- Eli Lilly
- Ipsen
- Cumberland Pharmaceuticals
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Chulalongkorn University
- Culpeper Surgery Center
- University of Washington
- Northwestern University
- Oregon Health and Science University
- Sheffield Hallam University
- University of Maryland
- University of Athens
- University of Bern
- Columbia University
- University of Chicago
- Magna Graecia University
- Culpeper Regional Health Systems
- University of Sao Paulo
- Paul G. Allen Family Foundation
- EvergreenHealth
- The Cleveland Clinic
Organization Involved with Phase 3 Indications (17)
- Allergan
- Bayer
- Duramed Research
- Ain Shams University
- Harvard University
- Queen's University, Belfast
- Justus Liebig University Giessen
- University of Pisa
- University of Rochester
- University of Valencia
- University of Calgary
- University of California, Los Angeles
- Pennsylvania State University
- Cantonal Hospital of St. Gallen
- University of Paris
- Strathmann AG&Co, Hamburg, Germany
- R3 Stem Cell
Organization Involved with Phase 2 Indications (21)
- Celgene
- Astellas
- Pfizer
- Wyeth
- Novartis
- Urigen
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Neurological Disorders and Stroke (NINDS)
- United States Army
- University of Pennsylvania
- Guangzhou Medical University
- Jilin University
- Oakland University
- Oregon College of Oriental Medicine
- University of California, San Diego
- University of Missouri
- Aquinox Pharamceuticals Inc
- Karolinska Institute
- Watson Pharmaceuticals
- Shenzhen maternal and child health care hospital
- Chinese Academy of Medical Sciences
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (16)
- Warner Chilcott
- Boston Urogynecology Associates
- Medical College of Wisconsin
- Poznan University
- University of Cagliari
- University of California, Davis
- Vanderbilt University
- Fundación Althaia Manresa
- Mount Auburn Hospital
- University of Gothenburg
- Scott and White Healthcare
- Rajavithi Hospital, Bangkok
- University of Tennessee, Chattanooga
- Department of Veteran Affairs
- Biomet
- Espacio Gaspar Clinic